[BDRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -50.10%
YoY- -99.31%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 149 149 116 116 234 234 89 41.12%
PBT -1,928 -1,928 -2,545 -2,545 -1,699 -1,699 -1,358 26.40%
Tax 144 144 248 248 169 169 205 -21.03%
NP -1,784 -1,784 -2,298 -2,298 -1,531 -1,531 -1,153 33.88%
Tax Rate - - - - - - - -
Total Cost 1,933 1,933 2,413 2,413 1,765 1,765 1,242 34.40%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,197.32 -1,197.32 -1,989.18 -1,989.18 -654.06 -654.06 -1,302.82 -5.48%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -7.19 -7.19 -185.31 -185.31 -124.33 -124.33 -94.32 -82.10%
EPS Diluted -7.19 -7.19 -185.31 -185.31 -124.33 -124.33 -94.32 -82.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.